InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: Reefrad post# 475767

Thursday, 05/19/2022 3:46:59 PM

Thursday, May 19, 2022 3:46:59 PM

Post# of 700389
Yeah right. Nothing to see here, move along.

The clinical trials update is a nothing burger and meaningless. The end point change has been publicly known for a long time. They submitted the update on the day of the presentation just as a cleaning up kind of thing. It has nothing to do with the share price or the journal article. It’s meaningless.


Everyone (including Northwest Bio) knew that they would be attacked when the data was revealed. Northwest Bio could have waited to have the data presented in a journal when they would be permitted to PR this information and somewhat control the narrative, and yet they did not. Instead they chose to have the data presented at a prestigious scientific conference, while they were embargoed by a journal. (almost like walking around NY City with blinders on, holding their wallets out)

Northwest Bio could have disclosed what the new endpoints were in their 10-K in 2021, but did not. Instead they only disclosed that the endpoints were changed as required.

Northwest Bio could have updated the clinical trials registry at any time, but they did not. Instead they chose to make the request on the day of the presentation. (btw- what do you think would have happened to the share price if the clinical trial registry was updated days prior to the presentation?)

Hmmmm, and you say that they just happen to know the exact number of participants (15) that were involved in the “attack” that day?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News